Table 1.
Characteristics of the included studies.
| References |
Sample size (EG/CG) |
Man (%) |
Mean age (EG/CG) |
Type of stroke | Disease duration (EG/CG) | Method of intervention | Comparison | Outcome |
Loss situation (EG/CG) |
|---|---|---|---|---|---|---|---|---|---|
| Teng et al. (32) | 55/55 | 65 | 59.47 ± 8.62/60.17 ± 10.68 | Ischemic stroke or hemorrhage | 60.17 ± 10.68/59.67 ± 11.28 d | MA+CR | CR | ①③ | N |
| Mao (33) | 39/39 | 47 | 57.3 ± 15.6/57.3 ± 15.6 | Ischemic stroke or hemorrhage | 78.2 ± 38.2/76.3 ± 37.3 d | MA+CR | CR | ②④ | N |
| Liu (34) | 25/25 | 68 | / | Ischemic stroke or hemorrhage | / | EA+CR | CR | ① | N |
| Wang et al. (35) | 30/30 | 65 | 53.27 ± 11.62/56.73 ± 9.32 | Ischemic stroke or hemorrhage | / | EA+CR | CR | ①④ | N |
| Niu et al. (36) | 75/75 | 54 | 52.06 ± 7.98/51.89 ± 10.24 | Ischemic stroke | / | MA+CR | CR | ①②④ | N |
| Liao et al. (37) | 30/30 | 55 | 56.2 ± 6.5/56.6 ± 6.6 | Ischemic stroke or hemorrhage | 54.6 ± 6.3/53.9 ± 6.5 d | MA+ CR | CR | ③④ | N |
| Yang et al. (38) | 34/33 | 55 | 68.00 ± 8/67.00 ± 8 | / | 14.7 ± 6.2/15.5 ± 6.2 d | MA+CR | CR | ①② | 2/1 |
| Wen et al. (39) | 30/30 | 52 | 64.00 ± 7.18/63.7 ± 6.98 | Ischemic stroke or hemorrhage | 5.70 ± 1.92/5.3 ± 1.90 m | MA+CR | CR | ①④ | N |
| Jiang et al. (40) | 40/40 | 58 | 60.15 ± 6.32/58.67 ± 8.03 | Ischemic stroke | 10.01 ± 3.29/9.85 ± 3.01 d | MA+CR | CR | ③④ | N |
| Hu (41) | 63/63 | 48 | 70.03 ± 2.29/69.96 ± 2.20 | Ischemic stroke or hemorrhage | 2.45 ± 0.34/2.56 ± 0.31 m | MA+CR | CR | ② | N |
| Zhang et al. (42) | 30/30 | 63 | 70.10 ± 4.51/69.03 ± 4.70 | Ischemic stroke | 23.03 ± 7.47/24.63 ± 11.77 d | EA+CR | CR | ② | N |
| Wang (43) | 20/20 | 30 | 61.8 ± 11.92/60.25 ± 10.39 | Ischemic stroke or hemorrhage | 30.20 ± 11.83/28.25 ± 13.01 d | MA+CR | CR | ③④ | N |
| Wang et al. (44) | 40/40 | 61 | 45.39 ± 11.42/42.29 ± 11.72 | Ischemic stroke | 24.05 ± 11.89/26.85 ± 16.10 d | MA+CR | CR | ① | N |
| Liu (45) | 56/56 | 55 | / | Ischemic stroke | / | MA+CR | CR | ①② | N |
| Xie et al. (46) | 47/47 | 53 | 55.16 ± 1.23/55.43 ± 1.17 | Ischemic stroke | 89.36 ± 11.45/90.72 ± 11.64 d | MA+CR | CR | ①② | N |
| Yang (47) | 40/40 | 58 | 51.35 ± 7.30/51.27 ± 7.46 | / | 21.40 ± 5.38/21.57 ± 5.54 | MA+CR | CR | ①④ | N |
| Zhuo et al. (48) | 20/22 | 55 | 63.25 ± 9.34/63.04 ± 9.16 | Ischemic stroke | 2.15 ± 1.03/2.27 ± 1.06 m | MA+CR | CR | ② | 3/2 |
| Yang (49) | 47/47 | 55 | / | Ischemic stroke or hemorrhage | / | MA+CR | CR | ①④ | 0/3 |
| Yao et al. (50) | 40/38 | 53 | 61.27 ± 5.38/62.27 ± 6.48 | / | 42.38 ± 14.23/44.23 ± 18.87 d | EA+CR | CR | ②⑤ | 5/7 |
| Wang et al. (51) | 50/50 | 50 | 53.8 ± 11.7/54.5 ± 13.6 | Ischemic stroke or hemorrhage | / | MA+CR | CR | ①②④ | N |
| Xing et al. (52) | 30/26 | 57 | 63.4 ± 8.5/60.9 ± 8.1 | Ischemic stroke or hemorrhage | / | MA+CR | CR | ③④ | N |
| Piao (53) | 53/53 | 63 | 60.37 ± 5.45/59.15 ± 5.29 | Ischemic stroke | 5.12 ± 1.39/5.33 ± 1.40 d | MA+CR | CR | ① | N |
| Qian et al. (54) | 35/35 | 53 | 70 ± 6/69 ± 6 | Ischemic stroke | 10.14 ± 3.37/10.54 ± 3.85 d | MA+CR | CR | ① | N |
| Wang et al. (55) | 40/40 | 63 | 66 ± 8/67 ± 9 | Ischemic stroke | 14.62 ± 6.17/15.45 ± 6.24 d | MA+CR | CR | ①②④ | N |
| Song et al. (56) | 35/35 | 57 | 60 ± 10/58 ± 10 | Ischemic stroke or hemorrhage | 2.8 ± 1.4/2.5 ± 1.6 m | MA+ CR | CR | ②④ | N |
| Lin et al. (57) | 30/29 | 63 | 65 ± 5/67 ± 7 | Ischemic stroke | 29.85 ± 18.10/30.05 ± 19.89 d | EA+CR | CR | ② | N |
| Zhang et al. (58) | 28/30 | 52 | 59.95 ± 8.71/61.12 ± 9.62 | Ischemic stroke or hemorrhage | 39.72 ± 18.73/42.11 ± 17.56 d | MA+CR | CR | ①④ | 7/5 |
| Zeng et al. (59) | 34/35 | 58 | / | Ischemic stroke or hemorrhage | 71.00 ± 42.76/68.00 ± 36.56 d | MA+CR | CR | ①④ | 6/5 |
| Tian et al. (60) | 25/25 | 58 | 68.19 ± 0.16/68.21 ± 0.15 | Ischemic stroke or hemorrhage | / | MA+CR | CR | ① | N |
| Li (61) | 60/60 | 61 | 60.25 ± 6.34/60.26 ± 6.33 | Ischemic stroke | / | MA+CR | CR | ① | N |
| Wei et al. (62) | 30/30 | 62 | 60.32 ± 7.93 ± 60.38 ± 8.01 | Ischemic stroke | / | EA+CR | CR | ③ | N |
| Zhang et al. (63) | 50/50 | 49 | 63.5 ± 3.4/64.1 ± 3.6 | Ischemic stroke | / | MA+CR | CR | ①⑤ | N |
| Zhou (64) | 30/30 | 63 | 53.76 ± 9.27/53.89 ± 9.52 | Ischemic stroke | 64.35 ± 31.65/64.15 ± 30.97 d | MA+CR | CR | ①② | N |
| Chen (65) | 48/48 | 53 | 60.47 ± 2.35/60.80 ± 2.19 | Ischemic stroke or hemorrhage | 42.66 ± 7.89/42.50 ± 7.31 d | MA+CR | CR | ①④ | N |
| Du (66) | 30/30 | 48 | 62.14 ± 9.48/66.49 ± 10.03 | Ischemic stroke | 26.00 ± 0.01/25.00 ± 0.01 d | MA+CR | CR | ②④ | N |
| Chen et al. (67) | 30/30 | 45 | 62.00 ± 5.12/61.77 ± 4.81 | Ischemic stroke or hemorrhage | 42.00 ± 5.52/43.40 ± 5.10 d | MA+CR | CR | ①③ | N |
| Xiong et al. (68) | 35/35 | 53 | 63.0 ± 7.23/65.3 ± 8.52 | Ischemic stroke or hemorrhage | 2.13 ± 0.85/2.51 ± 0.46 m | MA+CR | CR | ①③ | 1/1 |
| Jiang et al. (69) | 52/51 | 47 | 62.33 ± 7.72/62.37 ± 7.89 | Ischemic stroke or hemorrhage | 41.13 ± 18.80/44.22 ± 17.00 d | MA+CR | CR | ①④⑤ | 9/8 |
EG, Experimental group; CG, Control group; MA, manual acupuncture; EA, electroacupuncture; CR, cognitive rehabilitation; ① MMSE, Mental State Examination Scale; ② MoCA, Montreal Cognitive Assessment Scale; ③ LOTCA, Loewenstein Occupational Therapy Cognitive Assessment; ④ MBI, Modified Barthel Index; ⑤ FIM, Functional Independence Measure; N, no loss situation; /, not mention.